tradit
chines
herbal
medicin
tchm
wide
use
prevent
treatment
viral
infecti
diseas
howev
oper
mechan
tchm
remain
larg
obscur
mainli
complic
natur
fragment
natur
research
recent
year
systemat
methodolog
develop
discov
activ
compound
tchm
elucid
underli
mechan
review
summar
recent
progress
tchmbase
antivir
research
china
asian
countri
particular
review
focus
progress
target
key
step
viral
replic
cycl
key
cellular
compon
host
defens
system
recent
develop
central
standard
tchm
screen
databas
also
summar
tradit
chines
herbal
medicin
tchm
import
compon
tradit
chines
medicin
system
long
use
multipl
combin
compound
form
process
natur
product
similar
convent
medicin
tchm
prescript
overthecount
drug
today
tchm
account
prescript
drug
china
long
histori
medic
usag
drug
discoveri
point
view
screen
activ
lead
compound
tchm
extract
consid
effici
compar
random
screen
standard
combinatori
chemic
librari
function
compound
hit
like
discov
tchm
extract
biolog
screen
assay
chemic
properti
compound
often
druglik
eg
better
pharmacokinet
bioavail
tchmderiv
activ
compound
thu
often
better
lead
compound
chemic
improv
characterist
tchm
offer
major
opportun
find
novel
chemic
structur
activ
varieti
therapeut
target
howev
even
uniqu
advantag
modern
global
tchm
slow
difficult
issu
understand
oper
mechan
tchm
identifi
activ
compon
review
summar
recent
progress
advantag
tchmbase
antivir
research
china
particular
paper
follow
step
gener
viru
life
cycl
report
progress
assay
develop
knowledg
antivir
mechan
tchm
tchmderiv
compound
tchm
wide
use
prevent
treatment
viral
infecti
diseas
china
mani
asian
countri
howev
intern
commun
remain
uncertain
efficaci
tchm
lack
support
clinic
evid
collect
intern
standard
random
placebocontrol
doubleblind
multicent
clinic
studi
govern
put
forward
support
aim
intern
regulatori
approv
tchm
lead
pack
compound
also
known
danton
thcm
product
tasli
pharmaceut
china
may
becom
first
tradit
chines
medicin
receiv
food
drug
administr
fda
approv
unit
state
tchm
use
china
manag
ischaem
heart
diseas
current
global
phase
iii
trial
clinicaltrialsgov
identifi
grow
number
tchm
antivir
activ
also
garner
evid
experiment
andor
clinic
efficaci
tabl
show
partial
list
antivir
tchm
approv
china
food
drug
administr
sfda
tchm
respiratori
viral
infect
repres
major
drug
market
viral
replic
cycl
includ
attach
entri
host
cell
fig
transcript
viral
mrna
viral
genom
replic
fig
protein
synthesi
assembl
bud
progeni
viru
particl
fig
step
provid
target
inhibitor
entri
replic
eg
proteas
inhibitor
viral
polymeras
inhibitor
integras
inhibitor
among
other
assembl
bud
inhibitor
classifi
direct
antivir
agent
previou
studi
provid
evid
direct
antivir
activ
mani
medicin
herb
use
tchm
sun
wang
et
al
wang
et
al
zhao
han
definit
viru
depend
cellular
machineri
complet
replic
cycl
eg
cellular
peptidas
transcript
factor
elong
factor
follow
coevolut
host
mani
virus
establish
sophist
mechan
interact
host
immun
system
immun
evas
mechan
provid
cellular
target
antivir
drug
intervent
among
class
antivir
agent
immunomodul
abund
tchm
base
tcm
theori
remedi
contain
multipl
activ
compon
mainli
herb
multipl
target
compon
work
directli
therapeut
target
wherea
other
counteract
drug
toxic
enhanc
bioavail
medicin
thu
tchm
remedi
often
compos
hierarchi
differ
compon
socal
monarch
minist
assist
guid
compon
yu
et
al
consid
complic
natur
tchm
experi
laboratori
anim
consid
gold
standard
pharmacolog
screen
process
import
medic
evalu
reflect
efficaci
side
effect
toxic
medicin
whole
gener
tchm
whole
extract
often
test
first
abil
protect
anim
viral
challeng
fig
howev
vivo
method
costli
low
throughput
tchm
test
optim
cellbas
assay
often
carri
directli
initi
evalu
whole
extract
show
clinic
evid
antivir
activ
practic
base
assumpt
compound
direct
antivir
activ
present
whole
tchm
extract
compound
measur
abil
protect
cell
virusinduc
cytotox
fig
activityguid
fraction
agf
often
perform
subsequ
identificaton
activ
fraction
isol
pure
compound
koehn
carter
fig
basic
principl
agf
tchm
fraction
separ
antivir
activ
confirm
recent
year
improv
understand
viral
replic
mechan
cellular
molecular
level
highli
specif
assay
xiasangju
granul
guangyaoxingqunxiasangju
flu
rsv
influenza
huang
et
al
zhan
dong
highthroughput
capabl
develop
fig
assay
enhanc
chanc
success
agf
provid
data
understand
mechan
action
identifi
compound
addit
classic
bioscreen
computeraid
molecular
design
dockingbas
virtual
screen
technolog
also
appli
antivir
screen
tchm
progress
area
depend
heavili
avail
structur
databas
bioinformat
past
databas
scatter
among
individu
laboratori
includ
insuffici
number
compound
limit
associ
inform
howev
sever
larger
databas
recent
construct
tcm
databas
taiwan
http
tcmcmuedutw
built
team
led
prof
calvin
yuchian
chen
china
medic
univers
taiwan
contain
chemic
structur
compound
chen
use
databas
team
identifi
quinic
acid
protect
viru
challeng
anim
model
vitro
evalu
genipin
syring
acid
cucurbitin
fagarin
methyl
isoferul
deriv
potent
antiinfluenza
compound
block
viral
ion
channel
lin
et
al
use
approach
also
identifi
strong
antagonist
bind
hemagglutinin
subtyp
sialic
acid
chang
et
al
entri
host
cell
first
step
viral
life
cycl
machineri
proven
excel
target
antivir
therapeut
advanc
assay
develop
identifi
compound
inhibit
critic
step
viral
life
cycl
peng
mani
virus
cellsurfac
attach
accomplish
interact
cell
surfac
glycan
polysaccharid
observ
satur
cell
surfac
viral
attach
protein
inhibit
viral
entri
confirm
antivir
tcm
studi
tabl
polysaccharid
deriv
frequent
found
viral
entri
inhibitor
mechan
studi
show
sugar
target
viral
attach
andor
intern
step
mediat
specif
interact
viral
particl
cellsurfac
molecul
result
viral
serotypeor
host
cell
typedepend
activ
baba
et
al
marchetti
et
al
composit
sugar
unit
divers
linkag
chemistri
also
factor
determin
function
properti
target
specif
compound
thu
polysaccharid
consid
broadspectrum
viru
entri
inhibitor
deriv
display
signific
level
virusspecif
activ
zhou
meng
polysaccharid
also
ligand
immunoregulatori
cellsurfac
receptor
tolllik
receptor
might
also
function
immunomodul
takeda
et
al
attach
viral
surfac
protein
interact
cellsurfac
receptor
trigger
conform
chang
initi
entri
process
inhibit
format
entri
machineri
tannin
inhibit
bind
histoblood
group
antigen
hbga
zhang
et
al
requir
conform
chang
prevent
viral
entri
indic
tabl
asid
polysaccharid
tannin
identifi
entri
inhibitor
multipl
mechan
propos
activ
includ
abil
tannin
interact
precipit
protein
tannin
shown
inhibit
fusion
complet
hiv
infect
liu
et
al
although
polysaccharid
tannin
typic
druglik
molecul
display
broad
antivir
activ
develop
topic
appli
medicin
microbicid
activ
pursu
replic
repres
core
viral
life
cycl
involv
viral
protein
function
inhibitor
viral
proteas
polymeras
integras
helicas
revers
transcriptas
hiv
hcv
herpesvirus
clinic
success
current
antivir
agent
target
stage
consid
uniqu
scenario
develop
tchm
antivir
activ
focus
princip
stage
infect
tabl
compar
antientri
tchm
compound
target
replic
chemic
divers
virusspecif
furthermor
consid
cellular
machineri
requir
viral
replic
mechan
mani
antivir
tchm
involv
cellular
factor
assembl
releas
infecti
virion
final
step
viral
life
cycl
stage
vial
structur
protein
often
prestructur
protein
enteroviru
matur
assembl
viral
capsid
step
viral
genom
packag
capsid
intracellular
transport
envelop
envelop
virus
releas
despit
absolut
requir
sustain
viral
infect
antivir
agent
target
stage
develop
limit
partial
glycyrrhizin
inhibit
viral
replic
chen
et
al
due
limit
knowledg
packag
assembl
mechan
virus
result
limit
number
specif
assay
avail
studi
tchm
reveal
mechan
action
involv
viral
packag
assembl
summar
tabl
number
remain
limit
level
understand
still
preliminari
host
cell
invad
virus
must
escap
immun
respons
surviv
host
innat
adapt
respons
viral
infect
replic
oppos
viral
strategi
escap
block
host
immun
respons
excess
reaction
host
immun
respons
may
also
lead
tissu
damag
multiorgan
injuri
ferreromiliani
et
al
la
gruta
et
al
turn
may
caus
relat
diseas
tchm
enhanc
host
antivir
immun
respons
block
viral
immun
escap
mechan
therefor
display
antivir
activ
immunoregulatori
mechan
consid
mani
tchm
immunoregulatori
activ
tabl
mani
remedi
also
display
antivir
activ
class
tchm
includ
multitarget
compound
exampl
polysaccharid
potent
interferon
induc
good
viral
entri
inhibitor
anoth
exampl
glycyrrhizin
activ
entri
replic
chen
et
al
immunomodul
shinada
et
al
major
goal
current
research
meet
intern
standard
modern
tchm
achiev
goal
tchm
must
satisfi
requir
set
intern
standard
includ
evidencesupport
efficaci
particularli
random
doubleblind
placebocontrol
multicent
clinic
trial
safeti
assess
qualiti
control
central
standard
research
system
aim
achiev
better
understand
medicin
chemistri
mechan
action
tchm
fundament
achiev
goal
realiz
need
twelfth
fiveyear
plan
nation
econom
social
develop
peopl
republ
china
laid
nation
strategi
tcm
develop
compar
former
plan
reflect
equal
import
tcm
western
medicin
nation
level
project
support
develop
tcm
stipul
protect
research
ration
util
chines
materia
medica
resourc
establish
qualiti
evalu
standard
system
highest
prioriti
term
govern
support
http
wwwnewscn
initi
show
determin
solv
bottleneck
underdevelop
chines
materia
medica
thu
base
plan
expect
tcmbase
medic
system
greatli
enhanc
increas
fund
basic
research
improv
educ
govern
support
undoubtedli
result
advanc
phytochemistri
assay
develop
bioinformat
turn
provid
platform
technolog
tool
modern
commerci
tcm
support
central
local
govern
drug
screen
center
establish
china
recent
year
tabl
center
oper
scientist
extens
experi
global
pharmaceut
industri
equip
stateoftheart
equip
includ
robot
capabl
highthroughput
screen
larg
pharmaceut
compani
novarti
also
set
research
center
china
compound
origin
tchm
among
foci
drug
discoveri
inform
fragment
pose
signific
challeng
tcm
research
benefit
strong
financi
support
larg
tcmfocus
databas
becom
avail
tabl
comprehens
integr
databas
foreseen
greatli
enhanc
tchmbase
drug
discoveri
